Replies to post #384237 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

It will only gather dust. Not going anywhere. He expressed interest in the ER if they can get around Pfizer’s blockade, but doubtful.

[jammy32]

Wasn’t 2022 last year. Not following your timeline nasdaq 2020

[NASDAQ2020]

Elite's Monster AFFORDABLE Unique second generation IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone. It can also be used with CNS stimulants to make them abuse deterrent.
This holy grail of IR ADFs trials resume in 2023 due to COVID
Making others obsolete.
Sequest maybe too expensive for the market now .
Elite's cheaper ADF would be a better fit in todays market.

HammerPatent Pending


Quote Nasrat:

“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “



ELTP